ArticleBMC cancer2023

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.

Laura Spiers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.